| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/16/2011 | US20110144147 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 06/16/2011 | US20110144144 Ibuprofen and narcotic analgesic compositions |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110142953 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 06/16/2011 | US20110142952 Pharmaceutical Compositions |
| 06/16/2011 | US20110142951 Micelles for intracellular delivery of therapeutic agents |
| 06/16/2011 | US20110142950 Polymer micelles containing anthracylines for the treatment of cancer |
| 06/16/2011 | US20110142949 Chondroitinase treatment method for demyelination-related conditions and diseases |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142947 Novel formulations |
| 06/16/2011 | US20110142946 Drug sustained-release agent, adsorbent, functional food, mask and adsorption sheet |
| 06/16/2011 | US20110142945 Hydrophobic Active Agent Compositions and Related Methods |
| 06/16/2011 | US20110142944 Andrographis extract formulations |
| 06/16/2011 | US20110142943 Tamper-resistant pharmaceutical compositions of opiods and other drugs |
| 06/16/2011 | US20110142942 USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS |
| 06/16/2011 | US20110142941 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof |
| 06/16/2011 | US20110142940 Analgesic Apatitic Calcium-Phosphate Cement |
| 06/16/2011 | US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease |
| 06/16/2011 | US20110142938 Nanotubes as Mitochondrial Uncouplers |
| 06/16/2011 | US20110142937 Methods and Compositions To Treat Hemorrhagic Conditions of The Brain |
| 06/16/2011 | US20110142936 Implants and biodegradable fiducial markers |
| 06/16/2011 | US20110142935 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods |
| 06/16/2011 | US20110142934 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season |
| 06/16/2011 | US20110142933 Controlled Release Dosage Form of Tacrolimus |
| 06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
| 06/16/2011 | US20110142931 Soft tablet containing dextrose monohydrate |
| 06/16/2011 | US20110142930 Pharmaceutical Compositions of Atorvastatin |
| 06/16/2011 | US20110142929 Solid pharmaceutical formulations comprising bibw 2992 |
| 06/16/2011 | US20110142928 Process for the production of calcium compositions in a continuous fluid bed |
| 06/16/2011 | US20110142927 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142926 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142925 Film Coating For Tablets And Caplets |
| 06/16/2011 | US20110142924 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
| 06/16/2011 | US20110142923 Ophthalmic pharmaceutical compositions for the treatment of neoangiogenic pathologies of the eye |
| 06/16/2011 | US20110142922 Stabilized composition and method for dermatological treatment |
| 06/16/2011 | US20110142921 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 06/16/2011 | US20110142920 Treatment of length dependent neuropathy |
| 06/16/2011 | US20110142919 Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142917 Compositions and methods for treatment of ear disorders |
| 06/16/2011 | US20110142916 Adjuvants for Use in Vaccination |
| 06/16/2011 | US20110142915 Compositions and methods for inhibition of vegf |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142913 Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug |
| 06/16/2011 | US20110142912 Non-specific immunostimulating agents |
| 06/16/2011 | US20110142911 HIV epitopes and pharmaceutical composition containing same |
| 06/16/2011 | US20110142910 Clotting and Healing Compositions Containing Keratin Biomaterials |
| 06/16/2011 | US20110142909 Water-dispersible and multicomponent fibers from sulfopolyesters |
| 06/16/2011 | US20110142908 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication |
| 06/16/2011 | US20110142907 Polymer for tissue bonding |
| 06/16/2011 | US20110142906 Implant Devices that Differ by Release Profile and Methods of Making and Using Same |
| 06/16/2011 | US20110142905 Coated tablets with remaining degradation surface over the time |
| 06/16/2011 | US20110142903 Controlled-release, intra-articular therapeutic agent delivery compound, and a methodology for the controlled-release of an intra-articular therapeutic agent delivery compound |
| 06/16/2011 | US20110142902 Hypoxia Inducing Factor (HIF) Stabilising Glasses |
| 06/16/2011 | US20110142901 Sustained release composition |
| 06/16/2011 | US20110142897 Process for treatment of keratinous materials and kit for formulation of a cosmetic product |
| 06/16/2011 | US20110142896 Water-dispersible and multicomponent fibers from sulfopolyesters |
| 06/16/2011 | US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 06/16/2011 | US20110142889 Compositions and methods for oral drug delivery |
| 06/16/2011 | US20110142888 Film coating compositions based on polyvinyl alcohol-polyether graft copolymer/polyvinyl alcohol combinations with an improved moisture barrier effect |
| 06/16/2011 | US20110142887 Methods and compositions for liquidation of tumors |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142885 Spray-dried human plasma |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142883 Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts |
| 06/16/2011 | US20110142768 Calcium peroxyphosphates and use thereof in dental compositions |
| 06/16/2011 | US20110142767 RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS |
| 06/16/2011 | US20110142766 Effervescent Multi-Vitamin Formulation and Methods of Use Thereof |
| 06/16/2011 | US20110139152 Antibiotic microparticles for inhalation |
| 06/16/2011 | US20110139088 Apparatus and methods for dispensing pet care substances |
| 06/16/2011 | DE102009044891A1 Trägersystem zum Einschließen lipophiler Wirkstoffe und Öle in hoher Konzentration Support system for containing lipophilic active ingredients and oils in high concentration |
| 06/16/2011 | CA2821513A1 Glycerine based jelly compositions |
| 06/16/2011 | CA2784928A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | CA2784005A1 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | CA2783877A1 Ph sensitive compounds in taste masking within oral thin film strips |
| 06/16/2011 | CA2783732A1 Pharmaceutical composition comprising oligopeptides |
| 06/16/2011 | CA2783707A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/16/2011 | CA2783699A1 Compounds and methods of treating ocular disorders |
| 06/16/2011 | CA2783342A1 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | CA2782789A1 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | CA2782779A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/16/2011 | CA2782725A1 Process and product |
| 06/16/2011 | CA2780347A1 Partial dip coating of dosage forms for modified release |
| 06/16/2011 | CA2690450A1 Mesalamine suppository |
| 06/15/2011 | EP2332977A2 ActRII receptor polypeptides |
| 06/15/2011 | EP2332952A1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
| 06/15/2011 | EP2332587A1 Polyurethane dispersions for sealing teats of the mammary glands of animals which supply milk |
| 06/15/2011 | EP2332586A1 An adhesive patch |
| 06/15/2011 | EP2332585A1 An adhesive patch |
| 06/15/2011 | EP2332554A1 Anti-viral agent |
| 06/15/2011 | EP2332542A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2332530A1 The use of potassium 2-( - hydroxypentyl) benzoate in the manufacture of medicaments for preventing and/or treating senile dementia |
| 06/15/2011 | EP2332524A1 Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| 06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 06/15/2011 | EP2332522A2 Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 06/15/2011 | EP2332414A2 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 06/15/2011 | EP2332410A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 06/15/2011 | EP2332409A1 Process for preparing oxymorphone, naltrexone and buprenorphine |